Publications by authors named "Carola Metzig"

Claim this Profile
I
Impact of Posterior Vitreous Detachment on Treatment Outcomes in Diabetic Macular Edema.
Ferhina Ali, Sundeep Kasi, Namrata Saroj, Keith Baker, Desmond Thompson, Carola Metzig

Ophthalmol Retina· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
Jeffrey I Weitz, Rupert Bauersachs, Bastian Becker, Scott D Berkowitz, Maria C S Freitas, Carola Metzig

JAMA· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Retinal Perfusion Status in Eyes with Diabetic Macular Edema Receiving Intravitreal Aflibercept or Laser in VISTA Study.
Charles C Wykoff, Chirag Shah, Dilsher Dhoot, Hanna Rodriguez Coleman, Desmond Thompson, Carola Metzig

Ophthalmology· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EFFICACY AND SAFETY OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOCUSING ON PATIENTS WITH DIABETIC MACULAR EDEMA FROM JAPAN.
Hiroko Terasaki, Kunihiko Shiraki, Masahito Ohji, Carola Metzig, Thomas Schmelter

Retina· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies.
Paul Mitchell, Ian McAllister, Michael Larsen, Giovanni Staurenghi, Jean-Francois Korobelnik, Carola Metzig

Ophthalmol Retina· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies.
Giovanni Staurenghi, Nicolas Feltgen, Jennifer J Arnold, Todd A Katz, Carola Metzig

Br J Ophthalmol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Diabetic Macular Edema Eyes with Limited Early Response in the VISTA and VIVID Studies.
Dante Pieramici, Rishi P Singh, Andrea Gibson, Namrata Saroj, Robert Vitti, Carola Metzig

Ophthalmol Retina· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Baseline Central Retinal Thickness on Outcomes in the VIVID-DME and VISTA-DME Studies.
Edoardo Midena, Mark Gillies, Todd A Katz, Carola Metzig, Chengxing Lu

J Ophthalmol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema: Post Hoc Analyses from VISTA and VIVID.
Dilsher S Dhoot, Keith Baker, Namrata Saroj, Robert Vitti, Alyson J Berliner, Carola Metzig

Ophthalmology· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Diabetic Macular Edema Patients by Baseline Hemoglobin A1c: Analyses from VISTA and VIVID.
Rishi P Singh, Charles C Wykoff, David M Brown, Michael Larsen, Hiroko Terasaki, Carola Metzig

Ophthalmol Retina· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal Aflibercept Injection in Eyes With Substantial Vision Loss After Laser Photocoagulation for Diabetic Macular Edema: Subanalysis of the VISTA and VIVID Randomized Clinical Trials.
Charles C Wykoff, Dennis M Marcus, Edoardo Midena, Jean-François Korobelnik, Namrata Saroj, Carola Metzig

JAMA Ophthalmol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Jeffrey S Heier, Jean-François Korobelnik, David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Carola Metzig

Ophthalmology· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Frank G Holz, David S Boyer, Carola Metzig

Ophthalmology· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.
Britta Maurer, Nicole Graf, Beat A Michel, Ulf Müller-Ladner, László Czirják, Carola Metzig

Ann Rheum Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal aflibercept for diabetic macular edema.
Jean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, David S Boyer, Frank G Holz, Carola Metzig

Ophthalmology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.
Ludwig Kappos, Mark S Freedman, Chris H Polman, Gilles Edan, Hans-Peter Hartung, Carola Metzig

Lancet Neurol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis